Davenport & Co’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-113,670
| Closed | -$70K | – | 780 |
|
|
2019
Q3 | $70K | Sell |
113,670
-1,200
| -1% | -$739 | ﹤0.01% | 673 |
|
|
2019
Q2 | $71K | Hold |
114,870
| – | – | ﹤0.01% | 674 |
|
|
2019
Q1 | $127K | Hold |
114,870
| – | – | ﹤0.01% | 638 |
|
|
2018
Q4 | $52K | Sell |
114,870
-5,000
| -4% | -$2.26K | ﹤0.01% | 624 |
|
|
2018
Q3 | $192K | Hold |
119,870
| – | – | ﹤0.01% | 651 |
|
|
2018
Q2 | $43K | Hold |
119,870
| – | – | ﹤0.01% | 688 |
|
|
2018
Q1 | $34.8K | Hold |
119,870
| – | – | ﹤0.01% | 683 |
|
|
2017
Q4 | $116K | Buy |
119,870
+2,124
| +2% | +$2.06K | ﹤0.01% | 673 |
|
|
2017
Q3 | $178K | Hold |
117,746
| – | – | ﹤0.01% | 636 |
|
|
2017
Q2 | $146K | Buy |
117,746
+10,726
| +10% | +$13.3K | ﹤0.01% | 635 |
|
|
2017
Q1 | $110K | Hold |
107,020
| – | – | ﹤0.01% | 611 |
|
|
2016
Q4 | $110K | Buy |
107,020
+7,920
| +8% | +$8.14K | ﹤0.01% | 611 |
|
|
2016
Q3 | $103K | Sell |
99,100
-2,000
| -2% | -$2.08K | ﹤0.01% | 600 |
|
|
2016
Q2 | $148K | Buy |
101,100
+2,000
| +2% | +$2.92K | ﹤0.01% | 565 |
|
|
2016
Q1 | $115K | Buy |
99,100
+2,500
| +3% | +$2.9K | ﹤0.01% | 561 |
|
|
2015
Q4 | $116K | Sell |
96,600
-2,000
| -2% | -$2.4K | ﹤0.01% | 563 |
|
|
2015
Q3 | $159K | Hold |
98,600
| – | – | ﹤0.01% | 543 |
|
|
2015
Q2 | $205K | Hold |
98,600
| – | – | ﹤0.01% | 540 |
|
|
2015
Q1 | $293K | Buy |
98,600
+5,400
| +6% | +$16K | ﹤0.01% | 487 |
|
|
2014
Q4 | $294K | Hold |
93,200
| – | – | ﹤0.01% | 468 |
|
|
2014
Q3 | $316K | Buy |
93,200
+22,200
| +31% | +$75.3K | 0.01% | 441 |
|
|
2014
Q2 | $185K | Buy |
71,000
+6,000
| +9% | +$15.6K | ﹤0.01% | 555 |
|
|
2014
Q1 | $183K | Buy |
65,000
+5,000
| +8% | +$14.1K | ﹤0.01% | 543 |
|
|
2013
Q4 | $164K | Buy |
+60,000
| New | +$164K | ﹤0.01% | 536 |
|